NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 1 min ago

Notice of NIEHS Participation in PAR-20-125 "Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)"

Tue, 2020-03-10 11:50
Notice NOT-ES-20-013 from the NIH Guide for Grants and Contracts

General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19

Tue, 2020-03-10 05:28
Notice NOT-OD-20-083 from the NIH Guide for Grants and Contracts

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Tue, 2020-03-10 02:59
Funding Opportunity PA-20-135 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Guide Notices will be routed directly to the NIH awarding component signed on to the Emergency Guide Notice. Only applications submitted in response to an Emergency Guide Notice published by an Institute or Center (IC) will be allowed to apply to this Funding Opportunity Announcement.

NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

Tue, 2020-03-10 02:15
Notice NOT-OD-20-082 from the NIH Guide for Grants and Contracts

NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed)

Tue, 2020-03-10 02:00
Funding Opportunity RFA-AR-21-004 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)

Mon, 2020-03-09 02:37
Funding Opportunity RFA-AI-20-015 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to pair Bioengineers and Immunologists to leverage emerging innovative knowledge in physical and computational science for the design and development of an HIV-1 vaccine.

Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)

Fri, 2020-03-06 12:05
Funding Opportunity RFA-AI-20-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support basic, translational, and clinical research to improve the understanding of the effector or immunoregulatory potentials of NK cells for HIV prevention, control and/or eradication.

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Fri, 2020-03-06 11:54
Funding Opportunity RFA-CA-20-033 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required.

Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed)

Fri, 2020-03-06 11:44
Funding Opportunity RFA-AI-20-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to invite applications for innovative clinical, and preclinical/translational research to develop therapeutic vaccine strategies to improve treatment outcomes of active tuberculosis (TB) in the presence or absence of HIV co-infection.

Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed)

Fri, 2020-03-06 11:32
Funding Opportunity PAS-20-121 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving hepatitis B virus (HBV) cure in the presence of human immunodeficiency virus (HIV.

Notice to Announce NHLBI's Participation in the Human Health Exposure Analysis Resource (HHEAR) Program

Fri, 2020-03-06 11:25
Notice NOT-HL-20-753 from the NIH Guide for Grants and Contracts

NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)

Fri, 2020-03-06 11:01
Funding Opportunity RFA-AR-21-003 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)

Thu, 2020-03-05 11:40
Funding Opportunity PAR-20-125 from the NIH Guide for Grants and Contracts. The National Institute of General Medical Sciences, in conjunction with the Institutes/Centers of the National Institutes of Health (NIH) listed above in the "Components of Participating Organizations" section and the Indian Health Service (IHS), invites applications from federally recognized Tribes and Tribal organizations for the Native American Research Centers for Health (NARCH) initiative. The objective of the NARCH initiative is to support opportunities for conducting research and career enhancement opportunities to meet health needs prioritized by American Indian/Alaska Native (AI/AN) communities. The NARCH initiative also supports infrastructure and capacity building to ensure enable research sustainability and increased competitiveness of the Centers in their efforts of facilitating strong research environments relevant to the health needs of AI/AN communities.

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Thu, 2020-03-05 11:12
Funding Opportunity PAR-20-123 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.

Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)

Thu, 2020-03-05 11:07
Funding Opportunity PAR-20-127 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.

Research Education Program Grants for CryoEM and CryoET Curriculum Development (R25 Clinical Trial Not Allowed)

Thu, 2020-03-05 10:26
Funding Opportunity RFA-RM-20-010 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this Common Fund R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development in cryoelectron microscopy (cryoEM) and cryoelectron tomography (cryoET) for biology research.

Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional)

Thu, 2020-03-05 10:21
Funding Opportunity RFA-AT-21-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research applications that explore the impact of and the mechanisms by which complementary and integrative health approaches regulate the activities of glymphatic/lymphatic systems, or investigate the effect of complementary and integrative health approaches on the interactions between glymphatic/lymphatic functions and physiological/pathological processes. Proposed mechanistic studies may be in relevant animal models and/or human research participants. This FOA will not support clinical trials aiming to assess efficacy or effectiveness of clinical outcomes.

Pages